AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2020
May 30, 2020
30583_dirs_2020-05-29_e7d7cb7b-49be-454c-ae5d-d58da9e1d4b6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2020-05-27
Reporting Person: PYOTT DAVID E I (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-05-27 | Common Stock | A | 4300 | — | Acquired | 17940 | Direct |
Footnotes
F1: Restricted stock units granted on May 27, 2020. Price not applicable.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19